Supplier log in
Request for Tender - Supply of Venlafaxine to DHB Hospitals and/or to Community Pharmacies
Details
|
Tender Closed
|
|
| RFx ID : | 17596806 |
| Tender Name : | Request for Tender - Supply of Venlafaxine to DHB Hospitals and/or to Community Pharmacies |
| Reference # : | A913950 |
| Open Date : | Wednesday, 15 June 2016 8:00 AM (Pacific/Auckland UTC+12:00) |
| Close Date : | Monday, 11 July 2016 4:00 PM (Pacific/Auckland UTC+12:00) |
| Tender Type : | Request for Tenders (RFT) |
| Tender Coverage : | Sole Agency [?] |
| Categories : |
|
| Regions: |
|
| Exemption Reason : | None |
| Required Pre-qualifications : | None |
| Contact : |
Matthew Wolfenden procurement@pharmac.govt.nz |
| Alternate Physical Delivery Address : | |
| Alternate Physical Fax Number : | |
| Agency Address : | |
PHARMAC invites tenders for the supply of venlafaxine hydrochloride extended-release (venlafaxine) to DHB hospitals and/or to community pharmacies in New Zealand.
This request for tender (RFT) incorporates the following schedules:
(a) Schedule 1 sets out the definitions used in this RFT;
(b) Schedule 2 specifies the pharmaceuticals for which you may submit a Tender Bid in relation to community supply and/or hospital supply and provides background information to this RFT;
(c) Schedule 3 describes the process PHARMAC intends to follow in relation to this tender, and provides instructions on how to submit a Tender Bid in relation to community supply and/or hospital supply;
(d) Schedule 4 sets out terms that will apply if your Tender Bid in relation to community and/or hospital supply is awarded Sole Supply Status and/or Hospital Supply Status;
(e) Schedule 5 sets out the additional terms that will apply if your Tender Bid in relation to community supply is awarded Sole Supply Status;
(f) Schedule 6 sets out the additional terms that will apply if your Tender Bid in relation to hospital supply is awarded Hospital Supply Status; and
(g) Schedule 7 sets out any other special terms.
Please note that some clauses included in this RFT may not be applicable to this tender. PHARMAC has decided to retain substantially all of the clauses included in the standard PHARMAC invitation to tender to keep the terms of this RFT as familiar as possible to potential suppliers. This may mean that some clauses are not applicable in the context of a particular tender (which should be evident from the context).
For the avoidance of doubt, references in this RFT to “Price” and “Subsidy” are references to the price at which a pharmaceutical would be listed on the Pharmaceutical Schedule.
If you wish to submit a Tender Bid in relation to community supply and/or hospital supply, you must submit it to PHARMAC via the Government Electronic Tenders Service (GETS) (www.gets.govt.nz) no later than 4pm (New Zealand time) on Monday 11 July 2016.
If you have any inquiries about this RFT you should submit them via GETS or alternatively contact Matthew Wolfenden, Procurement Manager, by email procurement@pharmac.govt.nz. We look forward to receiving your tender.
This tender has been awarded to:
- Mylan New Zealand Ltd
Further Award Information:
PHARMAC is pleased to announce a decision to award a sole supply arrangement for venlafaxine to Mylan New Zealand Limited (Mylan) for its Enlafax XR brand from 1 June 2017 in DHB hospitals and from 1 September 2017 in the community. For further information please see the attached notification letter.
Award Date: Monday, 17 October 2016 (Pacific/Auckland UTC+13:00)
Date RFx was completed/updated: Monday, 11 July 2016 4:00 PM (Pacific/Auckland UTC+12:00)
